South Western Sydney Clinical School

Lessons learnt in evaluating the target of drug action in a phase 1 trial of oral albendazole –a benzimidazole carbamate anti-helminthic- in patients with cancer refractory to conventional treatments.

Chin MTM; Links MJ; Szwajcer; De Souza PL, 2007, 'Lessons learnt in evaluating the target of drug action in a phase 1 trial of oral albendazole –a benzimidazole carbamate anti-helminthic- in patients with cancer refractory to conventional treatments.', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Adelaide, Australia, pp. A79 - A79, presented at Clinical Oncological Society of Australia (COSA) Annual Scientific Meeting 2007, Adelaide, Australia, 01 November 2007, http://www3.interscience.wiley.com/cgi-bin/fulltext/118500669/PDFSTART

Back to Top